A prospective before-and-after trial of an educational intervention about pharmaceutical marketing

Academic Medicine

Volumn 79, Issue 11, 2004, Pages 1046-1050

  Agrawal, Sacha ^a   Saluja, Inderpal ^a   Kaczorowski, Janusz ^a  

^a MCMASTER UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ADVERTIZING; ARTICLE; CANADA; DRUG INDUSTRY; DRUG MARKETING; EDUCATION PROGRAM; FAMILY MEDICINE; HEALTH SURVEY; HUMAN; MEAL; MEDICAL EDUCATION; PHARMACY; PHYSICIAN; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUESTIONNAIRE; RESIDENT;

EID: 13644257732     PISSN: 10402446     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001888-200411000-00006     Document Type: Article

References (23)

1. Wazana A. Physicians and the pharmaceutical industry: is a gift ever just a gift? JAMA. 2000;283:373-80.
2. Gardner DM, Mintzes B, Ostry A. Direct-to-consumer prescription drug advertising in Canada: permission by default? CMAJ. 2003;169:425-7.
3. Relman AS. Separating continuing medical education from pharmaceutical marketing. JAMA. 2001;285:2009-12.
4. Moynihan R. Who pays for the pizza? Redefining the relationships between doctors and drug companies. 1: Entanglement. BMJ. 2003;326:1189-92.
5. Herxheimer A. Relationships between the pharmaceutical industry and patients' organisations. BMJ. 2003;326:1208-10.
6. Rennie D. Fair conduct and fair reporting of clinical trials. JAMA. 1999;282:1766-8.
7. Drazen JM, Curfman GD. Financial associations of authors. N Engl J Med. 2002;346:1901-2.
8. Morgan S, Barer M, Evans R. Health economists meet the fourth tempter: drug dependency and scientific discourse. Health Econ. 2000;9:659-67.
9. Chren MM, Landefeld CS, Murray TH. Doctors, drug companies, and gifts. JAMA. 1989;262:3448-51.
10. Wazana A, Primeau F. Ethical considerations in the relationship between physicians and the pharmaceutical industry. Psychiatr Clin North Am. 2002;25:647-63.
11. Moynihan R. Who pays for the pizza? Redefining the relationships between doctors and drug companies. 2: Disentanglement. BMJ. 2003;326:1193-6.
12. Dana J, Loewenstein G. A social science perspective on gifts to physicians from industry. JAMA. 2003;290:252-5.
13. Steinman MA, Shlipak MG, McPhee SJ. Of principles and pens: attitudes and practices of medicine housestaff toward pharmaceutical industry promotions. Am J Med. 2001;110:551-7.
14. Hodges B. Interactions with the pharmaceutical industry: experiences and attitudes of psychiatry residents, interns and clerks. CMAJ. 1995;153:553-9.
15. Lurie N, Rich EC, Simpson DE, et al. Pharmaceutical representatives in academic medical centers: interaction with faculty and housestaff. J Gen Intern Med. 1990;5:240-3.
16. Hopper JA, Speece MW, Musial JL. Effects of an educational intervention on residents' knowledge and attitudes toward interactions with pharmaceutical representatives. J Gen Intern Med. 1997;12:639-42.
17. Wilkes MS, Hoffman JR. An innovative approach to educating medical students about pharmaceutical promotion. Acad Med. 2001;76:1271-7.
18. McKinney WP, Schiedermayer DL, Lurie N, Simpson DE, Goodman JL, Rich EC. Attitudes of internal medicine faculty and residents toward professional interaction with pharmaceutical sales representatives. JAMA. 1990;264:1693-7.
19. Spencer JA, Jordan RK. Learner centred approaches in medical education. BMJ. 1999; 318:1280-3.
20. Kaufman DM. Applying educational theory in practice. BMJ. 2003;326:213-6.
21. Harvey, K. Prescribing rationally not fashionably [video]. Melbourne, Australia: World Health Organisation Drug Action Programme, 1993.
22. Vinson DC, McCandless B, Hosokawa MC. Medical students' attitudes toward pharmaceutical marketing: possibilities for change. Fam Med. 1993;25:31-3.
23. Anastasio GD, Little JM Jr. Pharmaceutical marketing: implications for medical residency training. Pharmacotherapy. 1996;16:103-7.